Mesa Biotech Overview

  • Founded
  • 2009

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 500

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $407M

Mesa Biotech General Information

Description

Developer of a molecular diagnostic test designed to treat infectious diseases. The company's test uses revolutionary technology which offers the simplicity, convenience, and procedural familiarity of traditional point of care rapid immunoassays while offering sensitivity, the specificity of laboratory-based molecular testing, enabling healthcare professionals to access actionable, laboratory-quality results at the point-of-care with sensitivity and specificity than current infectious disease rapid immunoassay tests.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Primary Office
  • 6190 Cornerstone Court East
  • Suite 220
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mesa Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 25-Feb-2021 $407M 0000 00000 Completed Generating Revenue
8. Grant 06-Nov-2020 000.00 0000 Completed Generating Revenue
7. Debt - PPP 03-May-2020 0000 Completed Generating Revenue
6. Later Stage VC (Series C) 28-Oct-2019 000 0000 0000 Completed Generating Revenue
5. Later Stage VC (Series B) 09-Jul-2018 0000 0000 0000 Completed Generating Revenue
4. Later Stage VC (Series A) 13-Feb-2018 0000 0000 0000 Completed Generating Revenue
3. Grant 01-Jun-2015 00.000 Completed Generating Revenue
2. Grant Completed Generating Revenue
1. Grant 11-Aug-2009 $100K Completed Generating Revenue
To view Mesa Biotech’s complete valuation and funding history, request access »

Mesa Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A 395,631 $0.000010 6% $7.59 $7.59 1x $7.59 3.98%
To view Mesa Biotech’s complete cap table history, request access »

Mesa Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostic test designed to treat infectious diseases. The company's test uses revolutionary te
Diagnostic Equipment
San Diego, CA
500 As of 2021
0000
0000 0000-00-00
000000&0 0000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000 000000000
Newark, CA
000000&0

00000-

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000000000 000000000
Raritan, NJ
0000 As of 0000
00.000
00 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mesa Biotech Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioChain Institute Formerly VC-backed Newark, CA 000000&0
00000-00000000 000 Formerly PE-Backed Raritan, NJ 0000 00.000 000000&0 00.000
00-00000000000 Formerly VC-backed Salt Lake City, UT 000 00.000 000000 - 000 00.000
0000000 00000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
00 00000000000 Corporate Backed or Acquired Santa Ana, CA 000 000000&0
You’re viewing 5 of 9 competitors. Get the full list »

Mesa Biotech Patents

Mesa Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180304260-A1 Fluidic test cassette Pending 21-Apr-2017 000000000000
CA-3062287-A1 Fluidic test cassette Pending 21-Apr-2017 000000000000
EP-3612306-A4 Fluidic test cassette Pending 21-Apr-2017 000000000000 0
AU-2018255430-A1 Fluidic test cassette Pending 21-Apr-2017 000000000000
EP-3612306-A1 Fluidic test cassette Pending 21-Apr-2017 B01L3/502723
To view Mesa Biotech’s complete patent history, request access »

Mesa Biotech Executive Team (10)

Name Title Board Seat Contact Info
Ingo Chakravarty Chief Executive Officer & President
Robert Cary Ph.D Co-Founder, Board Member & Chief Scientific Officer
William Brody MD Chairman
You’re viewing 3 of 10 executive team members. Get the full list »

Mesa Biotech Board Members (5)

Name Representing Role Since
Robert Cary Ph.D Mesa Biotech Co-Founder, Board Member & Chief Scientific Officer 000 0000
William Brody MD Self Chairman 000 0000
You’re viewing 2 of 5 board members. Get the full list »

Mesa Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mesa Biotech Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
American Recovery and Reinvestment Act Government 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Biomedical Advanced Research and Development Authority Government 000 0000 000000 0
California Citrus Research Board Other 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »